Cargando…
Low Z‐4OHtam concentrations are associated with adverse clinical outcome among early stage premenopausal breast cancer patients treated with adjuvant tamoxifen
Low steady‐state levels of active tamoxifen metabolites have been associated with inferior treatment outcomes. In this retrospective analysis of 406 estrogen receptor‐positive breast cancer (BC) patients receiving adjuvant tamoxifen as initial treatment, we have associated our previously reported th...
Autores principales: | Helland, Thomas, Naume, Bjørn, Hustad, Steinar, Bifulco, Ersilia, Kvaløy, Jan Terje, Sætersdal, Anna Barbro, Synnestvedt, Marit, Lende, Tone Hoel, Gilje, Bjørnar, Mjaaland, Ingvil, Weyde, Kjetil, Blix, Egil Støre, Wiedswang, Gro, Borgen, Elin, Hertz, Daniel Louis, Janssen, Emiel Adrianus Maria, Mellgren, Gunnar, Søiland, Håvard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8024735/ https://www.ncbi.nlm.nih.gov/pubmed/33252186 http://dx.doi.org/10.1002/1878-0261.12865 |
Ejemplares similares
-
Disseminated tumor cells as selection marker and monitoring tool for secondary adjuvant treatment in early breast cancer. Descriptive results from an intervention study
por: Synnestvedt, Marit, et al.
Publicado: (2012) -
Comparison of molecular and immunocytochemical methods for detection of disseminated tumor cells in bone marrow from early breast cancer patients
por: Gilje, Bjørnar, et al.
Publicado: (2014) -
Serum concentrations of active tamoxifen metabolites predict long-term survival in adjuvantly treated breast cancer patients
por: Helland, Thomas, et al.
Publicado: (2017) -
Effect of Genetic Variability in 20 Pharmacogenes on Concentrations of Tamoxifen and Its Metabolites
por: Chen, Yuanhuang, et al.
Publicado: (2021) -
Importance of endocrine treatment adherence and persistence in breast cancer survivorship: a systematic review
por: Eliassen, Finn Magnus, et al.
Publicado: (2023)